부동 단백질 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 동향, 예측(2026-2034년)

Growth Factors of antifreeze proteins Market

The global antifreeze proteins market was valued at USD 21.91 million in 2025 and is expected to grow from USD 24.13 million in 2026 to USD 56.34 million by 2034, registering a CAGR of 11.18% during the forecast period. North America dominated the global market with a 36.6% market share in 2025, supported by strong demand from the biotechnology, pharmaceutical, and frozen food industries.

Antifreeze proteins (AFPs) are naturally occurring proteins that inhibit ice crystal formation and recrystallization during freezing and thawing. These proteins are sourced from fish, insects, plants, and microorganisms and are increasingly produced through recombinant biotechnology for commercial applications. AFPs are widely used in cryopreservation, frozen food manufacturing, seafood preservation, regenerative medicine, stem cell storage, fertility treatment, and biological research. Growing investments in advanced cold-chain infrastructure, cell therapy, and premium frozen food production are significantly contributing to market expansion.

Market Trends

The market is witnessing rapid adoption of recombinant and fermentation-based antifreeze proteins that provide improved purity, consistency, and scalability. Manufacturers are increasingly developing blended cryoprotective systems by combining AFPs with hydrocolloids, sugars, and polyols to improve efficiency while reducing production costs. Premium frozen foods, seafood exports, regenerative medicine, and biologics storage continue to generate strong commercial demand. Technological innovations in recombinant protein production are also making AFPs more commercially viable across multiple industries.

Market Drivers

The growing need to improve cell viability, product quality, and freeze-thaw stability is one of the primary factors driving market growth. In the healthcare sector, antifreeze proteins enhance the preservation of stem cells, tissues, fertility samples, and biologics by minimizing ice crystal damage during storage. In the food industry, AFPs help maintain the texture and quality of frozen desserts, seafood, meat products, and bakery items by preventing ice recrystallization. Increasing demand for premium frozen food products and expanding global seafood exports further support market growth.

Market Restraints

Despite their advantages, the commercialization of antifreeze proteins is restricted by high production costs and limited large-scale manufacturing capacity. Recombinant production requires sophisticated biotechnology infrastructure, increasing overall product costs. Fish-derived AFPs also face allergen labeling concerns and raw material limitations. Additionally, less expensive alternatives such as hydrocolloids, emulsifiers, and conventional cryoprotectants continue to compete with AFP-based formulations, limiting widespread adoption in cost-sensitive industries.

Market Opportunities

Growing demand for advanced cryopreservation technologies presents substantial opportunities for antifreeze protein manufacturers. Cell therapy logistics, stem cell banking, organ preservation, fertility treatment, and biologics storage require high-performance cryoprotectants that improve post-thaw recovery. At the same time, premium frozen seafood, frozen desserts, and processed foods offer attractive commercial opportunities. Strategic partnerships between biotechnology companies, frozen food manufacturers, seafood processors, and research institutions are expected to accelerate product commercialization throughout the forecast period.

Segmentation Analysis

Based on source, recombinant and synthetic antifreeze proteins accounted for the largest market share in 2025 owing to their consistent purity, scalable production, and suitability for biomedical applications. Fish-derived AFPs remained the second-largest segment due to their proven effectiveness in controlling ice recrystallization.

By application, the medical and biopharmaceutical segment dominated the market in 2025 as AFPs are extensively used in stem cell banking, fertility preservation, tissue storage, and regenerative medicine. The food and beverage segment held the second-largest share, supported by increasing use in frozen desserts, seafood preservation, ready meals, and bakery products.

Based on form, dry AFP powders led the market because of their longer shelf life, ease of transportation, standardized activity, and convenient storage. Native liquid AFPs also maintain significant demand in research laboratories and specialized industrial applications.

Regional Outlook

North America remained the largest regional market with a value of USD 8.02 million in 2025, led by strong biotechnology research, pharmaceutical innovation, and growing demand for advanced cryopreservation solutions. The U.S. market reached USD 6.77 million during the same year due to widespread adoption across biomedical research, frozen food manufacturing, and regenerative medicine.

Europe recorded a market value of USD 6.23 million in 2025, supported by pharmaceutical cold-chain development, premium frozen food production, and marine biotechnology research. Germany and the U.K. continue to be major regional contributors.

The Asia Pacific market reached USD 5.09 million in 2025, driven by expanding seafood processing, aquaculture, frozen food manufacturing, and biotechnology research. China, Japan, and India are witnessing increasing investments in cold-chain logistics and recombinant protein production.

South America generated USD 1.10 million in 2025, benefiting from seafood exports and frozen meat processing, while the Middle East & Africa market reached USD 1.47 million, supported by premium foodservice, biomedical logistics, and temperature-controlled supply chains.

Competitive Landscape

The global antifreeze proteins market is moderately fragmented, with companies focusing on recombinant protein technology, fermentation capabilities, product purity, and application-specific solutions. Major players are strengthening their market positions through partnerships, acquisitions, product launches, and investments in biotechnology platforms. Leading companies include NICHIREI CORPORATION, KANEKA CORPORATION, A/F Protein Inc., MyBioSource, PROTOKINETIX, INC., BioCrick BioTech, CUSABIO TECHNOLOGY LLC, ProSpec-Tany TechnoGene Ltd., Sino Biological, Inc., and AquaBounty Technologies, Inc.

Recent industry developments include CUSABIO's expansion of recombinant AFP products in 2026, BioLife Solutions' acquisition of PanTHERA CryoSolutions in 2025, and Kaneka Corporation's launch of edible Type I antifreeze proteins for food applications.

Conclusion

The antifreeze proteins market is poised for strong growth as industries increasingly require advanced solutions for cryopreservation, frozen food quality, seafood preservation, and regenerative medicine. Rising investments in biotechnology, recombinant protein manufacturing, and premium cold-chain applications are expected to accelerate commercial adoption. With market value increasing from USD 21.91 million in 2025 to USD 24.13 million in 2026 and projected to reach USD 56.34 million by 2034, antifreeze proteins are expected to play an increasingly important role across healthcare, food processing, and life sciences industries worldwide.

Segmentation By Source, By Application, By Form, and Region

By Source * Recombinant / Synthetic AFPs

• Fish-Derived AFPs
• Microbial-Derived AFPs
• Plant-Derived AFPs
• Insect-Derived AFPs

By Application * Medical & Biopharmaceutical

• Food & Beverage
• Research & Academic Use
• Agriculture & Aquaculture
• Cosmetics & Personal Care
• Industrial & Materials Science

By Form * Native Liquid AFPs

• Dry AFP Powders
• Immobilized / Encapsulated AFP Systems

By Region * North America (By Source, By Application, By Form, and Country)

• U.S. (By Form)
• Canada (By Form)
• Mexico (By Form)
• Europe (By Source, By Application, By Form, and Country)
  • Germany (By Form)
  • France (By Form)
  • Italy (By Form)
  • U.K. (By Form)
  • Spain (By Form)
  • Rest of Europe (By Form)
• Asia Pacific (By Source, By Application, By Form, and Country)
  • China (By Form)
  • India (By Form)
  • Japan (By Form)
  • Australia (By Form)
  • Rest of Asia Pacific (By Form)
• South America (By Source, By Application, By Form, and Country)
  • Brazil (By Form)
  • Argentina (By Form)
  • Rest of South America (By Form)
• Middle East & Africa (By Source, By Application, By Form, and Country)
  • South Africa (By Form)
  • UAE (By Form)
  • Rest of Middle East & Africa (By Form)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Market Overview of Related/Parent Market
• 4.2. Supply Chain Analysis
• 4.3. Regulatory Analysis
• 4.4. Industry SWOT Analysis
• 4.5. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
• 4.6. Tariff Impact on the market

5. Global Antifreeze Proteins Market Analysis, Insights and Forecast, 2026-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Form(Value)
    • 5.2.1.1. Native Liquid AFPs
    • 5.2.1.2. Dry AFP Powders
    • 5.2.1.3. Immobilized / Encapsulated AFP Systems
  • 5.2.2. By Source (Value)
    • 5.2.2.1. Recombinant / Synthetic AFPs
    • 5.2.2.2. Fish-Derived AFPs
    • 5.2.2.3. Microbial-Derived AFPs
    • 5.2.2.4. Plant-Derived AFPs
    • 5.2.2.5. Insect-Derived AFPs
  • 5.2.3. By Application (Value)
    • 5.2.3.1. Medical & Biopharmaceutical
    • 5.2.3.2. Food & Beverage
    • 5.2.3.3. Research & Academic Use
    • 5.2.3.4. Agriculture & Aquaculture
    • 5.2.3.5. Cosmetics & Personal Care
    • 5.2.3.6. Industrial & Materials Science
  • 5.2.4. By Region (Value)
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East & Africa

6. North America Antifreeze Proteins Market Analysis, Insights and Forecast, 2026-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Form(Value)
    • 6.2.1.1. Native Liquid AFPs
    • 6.2.1.2. Dry AFP Powders
    • 6.2.1.3. Immobilized / Encapsulated AFP Systems
  • 6.2.2. By Source (Value)
    • 6.2.2.1. Recombinant / Synthetic AFPs
    • 6.2.2.2. Fish-Derived AFPs
    • 6.2.2.3. Microbial-Derived AFPs
    • 6.2.2.4. Plant-Derived AFPs
    • 6.2.2.5. Insect-Derived AFPs
  • 6.2.3. By Application (Value)
    • 6.2.3.1. Medical & Biopharmaceutical
    • 6.2.3.2. Food & Beverage
    • 6.2.3.3. Research & Academic Use
    • 6.2.3.4. Agriculture & Aquaculture
    • 6.2.3.5. Cosmetics & Personal Care
    • 6.2.3.6. Industrial & Materials Science
  • 6.2.4. By Country
    • 6.2.4.1. U.S.
      • 6.2.4.1.1. By Form(Value)
        • 6.2.4.1.1.1. Native Liquid AFPs
        • 6.2.4.1.1.2. Dry AFP Powders
        • 6.2.4.1.1.3. Immobilized / Encapsulated AFP Systems
    • 6.2.4.2. Canada
      • 6.2.4.2.1. By Form(Value)
        • 6.2.4.2.1.1. Native Liquid AFPs
        • 6.2.4.2.1.2. Dry AFP Powders
        • 6.2.4.2.1.3. Immobilized / Encapsulated AFP Systems
    • 6.2.4.3. Mexico
      • 6.2.4.3.1. By Form(Value)
        • 6.2.4.3.1.1. Native Liquid AFPs
        • 6.2.4.3.1.2. Dry AFP Powders
        • 6.2.4.3.1.3. Immobilized / Encapsulated AFP Systems

7. Europe Antifreeze Proteins Market Analysis, Insights and Forecast, 2026-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Form(Value)
    • 7.2.1.1. Native Liquid AFPs
    • 7.2.1.2. Dry AFP Powders
    • 7.2.1.3. Immobilized / Encapsulated AFP Systems
  • 7.2.2. By Source (Value)
    • 7.2.2.1. Recombinant / Synthetic AFPs
    • 7.2.2.2. Fish-Derived AFPs
    • 7.2.2.3. Microbial-Derived AFPs
    • 7.2.2.4. Plant-Derived AFPs
    • 7.2.2.5. Insect-Derived AFPs
  • 7.2.3. By Application (Value)
    • 7.2.3.1. Medical & Biopharmaceutical
    • 7.2.3.2. Food & Beverage
    • 7.2.3.3. Research & Academic Use
    • 7.2.3.4. Agriculture & Aquaculture
    • 7.2.3.5. Cosmetics & Personal Care
    • 7.2.3.6. Industrial & Materials Science
  • 7.2.4. By Country
    • 7.2.4.1. Germany
      • 7.2.4.1.1. By Form(Value)
        • 7.2.4.1.1.1. Native Liquid AFPs
        • 7.2.4.1.1.2. Dry AFP Powders
        • 7.2.4.1.1.3. Immobilized / Encapsulated AFP Systems
    • 7.2.4.2. U.K.
      • 7.2.4.2.1. By Form(Value)
        • 7.2.4.2.1.1. Native Liquid AFPs
        • 7.2.4.2.1.2. Dry AFP Powders
        • 7.2.4.2.1.3. Immobilized / Encapsulated AFP Systems
    • 7.2.4.3. France
      • 7.2.4.3.1. By Form(Value)
        • 7.2.4.3.1.1. Native Liquid AFPs
        • 7.2.4.3.1.2. Dry AFP Powders
        • 7.2.4.3.1.3. Immobilized / Encapsulated AFP Systems
    • 7.2.4.4. Italy
      • 7.2.4.4.1. By Form(Value)
        • 7.2.4.4.1.1. Native Liquid AFPs
        • 7.2.4.4.1.2. Dry AFP Powders
        • 7.2.4.4.1.3. Immobilized / Encapsulated AFP Systems
    • 7.2.4.5. Spain
      • 7.2.4.5.1. By Form(Value)
        • 7.2.4.5.1.1. Native Liquid AFPs
        • 7.2.4.5.1.2. Dry AFP Powders
        • 7.2.4.5.1.3. Immobilized / Encapsulated AFP Systems
    • 7.2.4.6. Rest of Europe
      • 7.2.4.6.1. By Form(Value)
        • 7.2.4.6.1.1. Native Liquid AFPs
        • 7.2.4.6.1.2. Dry AFP Powders
        • 7.2.4.6.1.3. Immobilized / Encapsulated AFP Systems

8. Asia Pacific Antifreeze Proteins Market Analysis, Insights and Forecast, 2026-2034

• 8.1. Key Findings / Summary
  • 8.1.1. By Form(Value)
    • 8.1.1.1. Native Liquid AFPs
    • 8.1.1.2. Dry AFP Powders
    • 8.1.1.3. Immobilized / Encapsulated AFP Systems
  • 8.1.2. By Source (Value)
    • 8.1.2.1. Recombinant / Synthetic AFPs
    • 8.1.2.2. Fish-Derived AFPs
    • 8.1.2.3. Microbial-Derived AFPs
    • 8.1.2.4. Plant-Derived AFPs
    • 8.1.2.5. Insect-Derived AFPs
  • 8.1.3. By Application (Value)
    • 8.1.3.1. Medical & Biopharmaceutical
    • 8.1.3.2. Food & Beverage
    • 8.1.3.3. Research & Academic Use
    • 8.1.3.4. Agriculture & Aquaculture
    • 8.1.3.5. Cosmetics & Personal Care
    • 8.1.3.6. Industrial & Materials Science
  • 8.1.4. By Country
    • 8.1.4.1. China
      • 8.1.4.1.1. By Form(Value)
        • 8.1.4.1.1.1. Native Liquid AFPs
        • 8.1.4.1.1.2. Dry AFP Powders
        • 8.1.4.1.1.3. Immobilized / Encapsulated AFP Systems
    • 8.1.4.2. India
      • 8.1.4.2.1. By Form(Value)
        • 8.1.4.2.1.1. Native Liquid AFPs
        • 8.1.4.2.1.2. Dry AFP Powders
        • 8.1.4.2.1.3. Immobilized / Encapsulated AFP Systems
    • 8.1.4.3. Japan
      • 8.1.4.3.1. By Form(Value)
        • 8.1.4.3.1.1. Native Liquid AFPs
        • 8.1.4.3.1.2. Dry AFP Powders
        • 8.1.4.3.1.3. Immobilized / Encapsulated AFP Systems
    • 8.1.4.4. Australia
      • 8.1.4.4.1. By Form(Value)
        • 8.1.4.4.1.1. Native Liquid AFPs
        • 8.1.4.4.1.2. Dry AFP Powders
        • 8.1.4.4.1.3. Immobilized / Encapsulated AFP Systems
    • 8.1.4.5. Rest of Asia Pacific
      • 8.1.4.5.1. By Form(Value)
        • 8.1.4.5.1.1. Native Liquid AFPs
        • 8.1.4.5.1.2. Dry AFP Powders
        • 8.1.4.5.1.3. Immobilized / Encapsulated AFP Systems

9. South America Antifreeze Proteins Market Analysis, Insights and Forecast, 2026-2034

• 9.1. Key Findings / Summary
  • 9.1.1. By Form(Value)
    • 9.1.1.1. Native Liquid AFPs
    • 9.1.1.2. Dry AFP Powders
    • 9.1.1.3. Immobilized / Encapsulated AFP Systems
  • 9.1.2. By Source (Value)
    • 9.1.2.1. Recombinant / Synthetic AFPs
    • 9.1.2.2. Fish-Derived AFPs
    • 9.1.2.3. Microbial-Derived AFPs
    • 9.1.2.4. Plant-Derived AFPs
    • 9.1.2.5. Insect-Derived AFPs
  • 9.1.3. By Application (Value)
    • 9.1.3.1. Medical & Biopharmaceutical
    • 9.1.3.2. Food & Beverage
    • 9.1.3.3. Research & Academic Use
    • 9.1.3.4. Agriculture & Aquaculture
    • 9.1.3.5. Cosmetics & Personal Care
    • 9.1.3.6. Industrial & Materials Science
  • 9.1.4. By Country
    • 9.1.4.1. Brazil
      • 9.1.4.1.1. By Form(Value)
        • 9.1.4.1.1.1. Native Liquid AFPs
        • 9.1.4.1.1.2. Dry AFP Powders
        • 9.1.4.1.1.3. Immobilized / Encapsulated AFP Systems
    • 9.1.4.2. Argentina
      • 9.1.4.2.1. By Form(Value)
        • 9.1.4.2.1.1. Native Liquid AFPs
        • 9.1.4.2.1.2. Dry AFP Powders
        • 9.1.4.2.1.3. Immobilized / Encapsulated AFP Systems
    • 9.1.4.3. Rest of South America
      • 9.1.4.3.1. By Form(Value)
        • 9.1.4.3.1.1. Native Liquid AFPs
        • 9.1.4.3.1.2. Dry AFP Powders
        • 9.1.4.3.1.3. Immobilized / Encapsulated AFP Systems

10. Middle East & Africa Antifreeze Proteins Market Analysis, Insights and Forecast, 2026-2034

• 10.1. Key Findings / Summary
  • 10.1.1. By Form(Value)
    • 10.1.1.1. Native Liquid AFPs
    • 10.1.1.2. Dry AFP Powders
    • 10.1.1.3. Immobilized / Encapsulated AFP Systems
  • 10.1.2. By Source (Value)
    • 10.1.2.1. Recombinant / Synthetic AFPs
    • 10.1.2.2. Fish-Derived AFPs
    • 10.1.2.3. Microbial-Derived AFPs
    • 10.1.2.4. Plant-Derived AFPs
    • 10.1.2.5. Insect-Derived AFPs
  • 10.1.3. By Application (Value)
    • 10.1.3.1. Medical & Biopharmaceutical
    • 10.1.3.2. Food & Beverage
    • 10.1.3.3. Research & Academic Use
    • 10.1.3.4. Agriculture & Aquaculture
    • 10.1.3.5. Cosmetics & Personal Care
    • 10.1.3.6. Industrial & Materials Science
  • 10.1.4. By Country
    • 10.1.4.1. UAE
      • 10.1.4.1.1. By Form(Value)
        • 10.1.4.1.1.1. Native Liquid AFPs
        • 10.1.4.1.1.2. Dry AFP Powders
        • 10.1.4.1.1.3. Immobilized / Encapsulated AFP Systems
    • 10.1.4.2. South Africa
      • 10.1.4.2.1. By Form(Value)
        • 10.1.4.2.1.1. Native Liquid AFPs
        • 10.1.4.2.1.2. Dry AFP Powders
        • 10.1.4.2.1.3. Immobilized / Encapsulated AFP Systems
    • 10.1.4.3. Rest of Middle East & Africa
      • 10.1.4.3.1. By Form(Value)
        • 10.1.4.3.1.1. Native Liquid AFPs
        • 10.1.4.3.1.2. Dry AFP Powders
        • 10.1.4.3.1.3. Immobilized / Encapsulated AFP Systems

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Antifreeze Proteins Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

• 12.1. NICHIREI CORPORATION.
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Application Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent Developments
• 12.2. KANEKA CORPORATION
• 12.3. A/F Protein Inc.
• 12.4. MyBioSource
• 12.5. PROTOKINETIX, INC.
• 12.6. BioCrick BioTech
• 12.7. CUSABIO TECHNOLOGY LLC
• 12.8. ProSpec-Tany TechnoGene Ltd.
• 12.9. Sino Biological, Inc.
• 12.10. AquaBounty Technologies, Inc.

13. Strategic Recommendations

14. Appendix